
Join to View Full Profile
55 Fruit StBoston, MA 02114
Phone+1 617-724-4000
Dr. Piotrowska is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2012 - 2016
- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2011
- Yale School of MedicineClass of 2008
Certifications & Licensure
- MA State Medical License 2010 - 2027
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rapid Plasma Genotyping For Early Initiation Of Erlotinib In EGFR Mutant Lung Cancer Start of enrollment: 2016 Jun 01
- A Study of EGF816 and Gefitinib in TKI-naïve EGFR-mutant Non-Small Cell Lung Cancer Start of enrollment: 2017 Oct 31
- A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer Start of enrollment: 2018 Jan 31
- Join now to see all
Publications & Presentations
PubMed
- Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherap...Zofia Piotrowska, Antonio Passaro, Danny Nguyen, Gerrina Ruiter, Ross A Soo
Journal of Clinical Oncology. 2025-07-20 - ORCHARD: Osimertinib Plus Necitumumab in Patients With Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With a Secondary Epidermal Growth F...Jonathan W Riess, Adrianus J de Langen, Santiago Ponce, Sarah B Goldberg, Zofia Piotrowska
JCO Precision Oncology. 2025-06-01 - 5 citationsAn ultrasensitive method for detection of cell-free RNA.Monica C Nesselbush, Bogdan A Luca, Young-Jun Jeon, Isabel Jabara, Catherine B Meador
Nature. 2025-05-01
Journal Articles
- Oxford University Press Has Registered This DOI Pre-PublicationR S Heist, Z Piotrowska, C G Azzoli, A T Shaw, I T Lennes, L V Sequist, J F Gainor, Oxford University Press
- EGFR Exon 20 Insertion Mutations Display Sensitivity to Hsp90 Inhibition in Preclinical Models and Lung AdenocarcinomasLecia V Sequist, Zofia Piotrowska, Clinical Cancer Research
Press Mentions
- Withdrawn NSCLC Drug: Was Ambitious Phase 3 Trial Design to Blame?March 5th, 2025
- Medical Mysteries: She Went Undiagnosed Until Almost Too LateMay 25th, 2024
- Highlights at ASCO22: Advancements in NSCLC TherapiesJune 24th, 2022
- Join now to see all
Grant Support
- Non-genomic resistance mechanisms in EGFR-mutant lung cancerMASSACHUSETTS GENERAL HOSPITAL2009–2027
Other Languages
- French, Polish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: